Natco Pharma Limited has made a regulatory disclosure to both BSE Limited and National Stock Exchange of India Limited regarding their Q2 FY27 earnings conference call.
The company provided the audio weblink for their earnings conference call that was held on 13th November 2026. This disclosure was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The audio recording of the earnings conference call is available on the company's website at the provided URL: https://admin.natcopharma.co.in/wp-content/uploads/2026/08/Edited-MP3.mp3
The communication was digitally signed by Venkat Ramesh Chekuri, who serves as Company Secretary & Compliance Officer of Natco Pharma Limited, on 13th November 2026 at 20:32:11 IST.